Glaxo Veteran Directs Infirst’s Jump Into Differentiated OTCs
This article was originally published in The Pink Sheet Daily
Executive Summary
U.K. biotech SEEK launches infirst HEALTHCARE to focus on commercializing consumer products, while the firm’s pipeline continues developing. Former GlaxoSmithKline exec Manfred Scheske leads infirst as it prepares cough remedy and analgesic launches in multiple markets.
You may also be interested in...
U.K.’s Ario Pharma Raises $3M Series A For Cough Therapy
New spin-out Ario Pharma is targeting idiopathic cough and cough associated with COPD for Phase II studies of its TRPV1 ion channel antagonist, supported by $3 million in financing from VCs in the U.S. and Europe.
PLx Pharma Proposes “GI-Safer” OTC Aspirin In New Drug Application
The firm files a rare new drug application for an OTC product, a formulation of aspirin and phosphatidylcholine designed to be more tolerable to the gastrointestinal tract. The involvement of OTC veterans Peter Mann and Michael Valentino on PLx’s board suggests strong market potential.
GSK Consumer Vet Scheske Sees OTC Potential In Biotech PepTcell's Portfolio
PepTcell is in the late stages of developing a potential blockbuster cough suppressant, says Manfred Scheske, head of the U.K. biotech's consumer business